| Market Cap | ₹2,214Cr |
| ROE | 0.85% |
| P/E Ratio(TTM) | 218.96 |
| EPS(TTM) | 0.82 |
| P/B Ratio | 1.85 |
| Dividend Yield | 0.45% |
| Industry P/E | 31.99 |
| Book Value | 96.86 |
| Debt to Equity | 0.57 |
| Face Value | 2 |
| Managing Director | Sameer Hiremath |
| Founded | 1988 |
| NSE Symbol | HIKAL |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 64.36 | ||
| Neuland Laboratories | NA (0.00%) | 69.64 | ||
| Acutaas Chemicals | NA (0.00%) | 55.69 | ||
| Jubilant Pharmova | NA (0.00%) | 34.64 |